Gruber James R. insider trades
Gruber James R. has filed 7 Form 4s with the SEC that we hold, all for Eton Pharmaceuticals, Inc. (ETON), as Chief Financial Officer. Across all of them we count 0 purchases worth $0 and 2 sales worth $673.7K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 39,082 shares of Eton Pharmaceuticals, Inc. worth $631.6K, dated 2025-08-19. The first filing on our record is dated 2022-07-18 and the latest 2026-01-14.
Eton Pharmaceuticals, Inc. (ETON)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-08-19 | S, sale reported on Form 4 | 39,082 | $631.6K | 2025-08-20 |
| 2025-08-20 | S, sale reported on Form 4 | 2,631 | $42.1K | 2025-08-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1923165) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms